Abstract
Background Comorbid conditions are prevalent in asthma patients but its impact on the economic burden of asthma is not well understood. To estimate the excess direct medical costs in patients with asthma, accounting for both the costs attributable to asthma and to comorbidities.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have